Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 99 | $16,840,978 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Nov 2024 16:18 | DNLI | Denali Therapeutics Inc | SCHENKEIN DAVID P | Director | 11 Nov 2024 | Sale | 27,129 | 32.09 | 870,570 | D |
| 13 Nov 2024 16:18 | DNLI | Denali Therapeutics Inc | SCHENKEIN DAVID P | Director | 11 Nov 2024 | Sale | 32,312 | 32.87 | 1,062,095 | D |
| 12 Nov 2024 16:44 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 07 Nov 2024 | Sale | 12,333 | 29.68 | 366,043 | D |
| 12 Nov 2024 16:44 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 07 Nov 2024 | Sale | 2,925 | 30.72 | 89,856 | D |
| 12 Nov 2024 16:44 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 07 Nov 2024 | Sale | 300 | 31.29 | 9,387 | D |
| 12 Nov 2024 16:43 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 07 Nov 2024 | Sale | 1,020 | 30 | 30,600 | D |
| 05 Nov 2024 16:21 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 01 Nov 2024 | Sale | 3,080 | 27.07 | 83,376 | D |
| 22 Oct 2024 16:30 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 18 Oct 2024 | Sale | 40,000 | 27.69 | 1,107,600 | D |
| 02 Oct 2024 16:37 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 30 Sep 2024 | Sale | 30,000 | 29.03 | 870,900 | D |
| 16 Sep 2024 16:17 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 13 Sep 2024 | Sale | 1,020 | 30 | 30,600 | D |
| 04 Sep 2024 18:26 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 03 Sep 2024 | Sale | 100 | 25.37 | 2,537 | D |
| 04 Sep 2024 18:26 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 03 Sep 2024 | Sale | 2,980 | 24.99 | 74,470 | D |
| 22 Aug 2024 16:16 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 20 Aug 2024 | Sale | 2,260 | 23.79 | 53,765 | D |
| 22 Aug 2024 16:15 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 20 Aug 2024 | Sale | 1,727 | 23.79 | 41,085 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 21 Aug 2024 | Sale | 2,547 | 24.78 | 63,115 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 20 Aug 2024 | Sale | 3,353 | 23.54 | 78,930 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 20 Aug 2024 | Sale | 2,453 | 23.79 | 58,357 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 21 Aug 2024 | Sale | 5,907 | 24.96 | 147,439 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 21 Aug 2024 | Sale | 14,098 | 24.41 | 344,132 | D |
| 22 Aug 2024 16:14 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 20 Aug 2024 | Sale | 2,453 | 23.79 | 58,357 | D |
| 15 Aug 2024 16:10 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 13 Aug 2024 | Sale | 2,272 | 22.89 | 52,006 | D |
| 15 Aug 2024 16:09 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 13 Aug 2024 | Sale | 2,337 | 22.89 | 53,494 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Jul 2024 | Sale | 100 | 22.8 | 2,280 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Jul 2024 | Sale | 29,900 | 22.12 | 661,388 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Jun 2024 | Sale | 688 | 21.79 | 14,992 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 01 Jul 2024 | Sale | 100 | 22.86 | 2,286 | D |
| 03 Jul 2024 21:13 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 01 Jul 2024 | Sale | 2,980 | 22.12 | 65,918 | D |
| 10 Jun 2024 20:06 | DNLI | Denali Therapeutics Inc | COOK JENNIFER E. | Director | 06 Jun 2024 | Sale | 1,458 | 21.73 | 31,682 | D |
| 17 May 2024 16:28 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 May 2024 | Sale | 1,674 | 20.39 | 34,133 | D |
| 17 Apr 2024 17:14 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Apr 2024 | Sale | 1,666 | 18.29 | 30,471 | D |
| 02 Apr 2024 18:07 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 01 Apr 2024 | Sale | 92,500 | 20.5 | 1,896,250 | D |
| 19 Mar 2024 16:27 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Mar 2024 | Sale | 1,666 | 20.1 | 33,487 | D |
| 20 Feb 2024 17:38 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Feb 2024 | Sale | 1,666 | 18.37 | 30,604 | D |
| 15 Feb 2024 21:16 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Feb 2024 | Sale | 2,750 | 17.29 | 47,548 | D |
| 15 Feb 2024 21:15 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 13 Feb 2024 | Sale | 9,589 | 17.29 | 165,794 | D |
| 15 Feb 2024 21:14 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 14 Feb 2024 | Sale | 1,405 | 17.79 | 24,995 | D |
| 15 Feb 2024 21:14 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 13 Feb 2024 | Sale | 2,784 | 17.29 | 48,135 | D |
| 15 Feb 2024 21:14 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 14 Feb 2024 | Sale | 20,128 | 17.66 | 355,460 | D |
| 15 Feb 2024 21:14 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 13 Feb 2024 | Sale | 2,716 | 17.29 | 46,960 | D |
| 18 Jan 2024 18:26 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 16 Jan 2024 | Sale | 1,666 | 18.42 | 30,688 | D |
| 12 Jan 2024 20:18 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 10 Jan 2024 | Sale | 4,668 | 19.02 | 88,785 | D |
| 11 Jan 2024 17:28 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 09 Jan 2024 | Sale | 7,818 | 19.78 | 154,640 | I |
| 09 Jan 2024 19:35 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 05 Jan 2024 | Sale | 9,972 | 19.43 | 193,756 | I |
| 09 Jan 2024 19:34 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 05 Jan 2024 | Sale | 3,208 | 19.43 | 62,331 | D |
| 09 Jan 2024 19:34 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 05 Jan 2024 | Sale | 9,972 | 19.43 | 193,756 | I |
| 09 Jan 2024 19:33 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 05 Jan 2024 | Sale | 17,483 | 19.43 | 339,695 | I |
| 18 Dec 2023 19:30 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Dec 2023 | Sale | 1,666 | 23.39 | 38,968 | D |
| 16 Nov 2023 18:14 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Nov 2023 | Sale | 1,666 | 19.13 | 31,871 | D |
| 18 Oct 2023 16:44 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 16 Oct 2023 | Sale | 1,666 | 20.66 | 34,420 | D |
| 19 Sep 2023 16:45 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Sep 2023 | Sale | 40 | 24.35 | 974 | D |
| 19 Sep 2023 16:45 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Sep 2023 | Sale | 1,626 | 23.6 | 38,374 | D |
| 25 Aug 2023 17:36 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 23 Aug 2023 | Sale | 2,522 | 23.17 | 58,435 | I |
| 25 Aug 2023 17:30 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 23 Aug 2023 | Sale | 2,522 | 23.22 | 58,561 | I |
| 23 Aug 2023 16:34 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 21 Aug 2023 | Sale | 2,478 | 22.6 | 56,003 | I |
| 23 Aug 2023 16:33 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 21 Aug 2023 | Sale | 2,478 | 22.59 | 55,978 | I |
| 23 Aug 2023 16:32 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 21 Aug 2023 | Sale | 2,309 | 22.59 | 52,160 | I |
| 23 Aug 2023 16:31 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 21 Aug 2023 | Sale | 1,419 | 22.6 | 32,069 | D |
| 17 Aug 2023 18:42 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 15 Aug 2023 | Sale | 1,666 | 24.3 | 40,484 | D |
| 16 Aug 2023 18:20 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 14 Aug 2023 | Sale | 2,768 | 23.79 | 65,851 | I |
| 16 Aug 2023 18:19 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 14 Aug 2023 | Sale | 2,772 | 23.67 | 65,613 | I |
| 14 Aug 2023 17:13 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 10 Aug 2023 | Sale | 2,526 | 25.03 | 63,226 | I |
| 14 Aug 2023 17:12 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 10 Aug 2023 | Sale | 2,857 | 24.15 | 68,997 | I |
| 14 Aug 2023 17:11 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 10 Aug 2023 | Sale | 2,853 | 24.18 | 68,986 | I |
| 19 Jul 2023 17:10 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 18 Jul 2023 | Sale | 9,702 | 30.01 | 291,157 | I |
| 19 Jul 2023 17:10 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 17 Jul 2023 | Sale | 10,000 | 29.6 | 296,000 | I |
| 19 Jul 2023 17:09 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 17 Jul 2023 | Sale | 1,666 | 29.6 | 49,314 | D |
| 30 Jun 2023 17:21 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 28 Jun 2023 | Sale | 1,114 | 29.98 | 33,398 | D |
| 30 Jun 2023 17:21 | DNLI | Denali Therapeutics Inc | SATO VICKI L | Director | 28 Jun 2023 | Sale | 552 | 29.55 | 16,312 | D |
| 17 May 2023 16:56 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 15 May 2023 | Sale | 800 | 29.23 | 23,384 | I |
| 17 May 2023 16:56 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 15 May 2023 | Sale | 9,200 | 28.55 | 262,660 | I |
| 24 Apr 2023 19:10 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 21 Apr 2023 | Sale | 24,800 | 25.15 | 623,720 | I |
| 24 Apr 2023 19:10 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 20 Apr 2023 | Sale | 200 | 25 | 5,000 | I |
| 14 Apr 2023 18:27 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 13 Apr 2023 | Sale | 4,898 | 25.04 | 122,646 | I |
| 14 Apr 2023 18:27 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 12 Apr 2023 | Sale | 5,102 | 25.04 | 127,754 | I |
| 17 Feb 2023 16:20 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 15 Feb 2023 | Sale | 1,476 | 29.4 | 43,394 | I |
| 15 Feb 2023 19:02 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 13 Feb 2023 | Sale | 2,119 | 30.1 | 63,782 | D |
| 15 Feb 2023 19:01 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 13 Feb 2023 | Sale | 3,497 | 30.09 | 105,225 | I |
| 15 Feb 2023 19:01 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 13 Feb 2023 | Sale | 25,000 | 30.08 | 752,000 | I |
| 15 Feb 2023 19:01 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 13 Feb 2023 | Sale | 8,815 | 30.09 | 265,243 | I |
| 14 Feb 2023 19:06 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 13 Feb 2023 | Sale | 2,548 | 30.1 | 76,695 | I |
| 14 Feb 2023 19:06 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 10 Feb 2023 | Sale | 818 | 29.8 | 24,376 | I |
| 13 Feb 2023 19:14 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 10 Feb 2023 | Sale | 25,000 | 29.1 | 727,500 | I |
| 13 Feb 2023 19:14 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 09 Feb 2023 | Sale | 3,433 | 30.59 | 105,015 | I |
| 10 Feb 2023 18:12 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 08 Feb 2023 | Sale | 1,521 | 30.88 | 46,968 | I |
| 10 Feb 2023 18:11 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 08 Feb 2023 | Sale | 1,521 | 30.89 | 46,984 | I |
| 10 Feb 2023 18:10 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 08 Feb 2023 | Sale | 1,377 | 30.88 | 42,522 | D |
| 19 Jan 2023 17:09 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 17 Jan 2023 | Sale | 114 | 29.87 | 3,405 | I |
| 19 Jan 2023 17:09 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 17 Jan 2023 | Sale | 9,886 | 29.53 | 291,934 | I |
| 10 Jan 2023 16:51 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 09 Jan 2023 | Sale | 1,459 | 28.48 | 41,552 | I |
| 09 Jan 2023 21:43 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 06 Jan 2023 | Sale | 1,451 | 28.67 | 41,600 | I |
| 09 Jan 2023 21:43 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 05 Jan 2023 | Sale | 2,636 | 28.44 | 74,968 | I |
| 09 Jan 2023 21:42 | DNLI | Denali Therapeutics Inc | KROGNES STEVE E. | Director | 05 Jan 2023 | Sale | 2,970 | 28.44 | 84,467 | D |
| 09 Jan 2023 21:41 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 05 Jan 2023 | Sale | 2,636 | 28.44 | 74,968 | I |
| 09 Jan 2023 21:41 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 05 Jan 2023 | Sale | 4,800 | 28.44 | 136,512 | I |
| 09 Jan 2023 16:05 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 04 Jan 2023 | Sale A | 2,912 | 28.7 | 83,574 | I |
| 05 Jan 2023 21:08 | DNLI | Denali Therapeutics Inc | HO CAROLE | Chief Medical Officer | 04 Jan 2023 | Sale | 2,913 | 28.69 | 83,574 | I |
| 05 Jan 2023 21:07 | DNLI | Denali Therapeutics Inc | SCHUTH ALEXANDER O. | COFO and Secretary | 04 Jan 2023 | Sale | 2,912 | 28.7 | 83,574 | D |
| 05 Jan 2023 21:07 | DNLI | Denali Therapeutics Inc | WATTS RYAN J. | President and CEO | 04 Jan 2023 | Sale | 5,029 | 28.73 | 144,483 | I |
| 28 Nov 2022 19:30 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 23 Nov 2022 | Sale | 20,000 | 30.48 | 609,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)